Product Details

Jamp Amoxi Clav Suspension

Amoxicillin + Clavulanic Acid
200 mg + 28.5 mg/5 mL
Powder for Oral Suspension


DIN/PIN/NPN

02539411

Manufacturer

Jamp Pharma Corporation

Formulary Listing Date

2024-09-27  

Unit Price

0.1373

Amount MOH Pays

0.1373

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Amoxicillin + Clavulanic Acid: Amoxicillin/clavulanic acid is not recommended as first line treatment for acute otitis media and sinusitis. Antibiotic resistance (H. influenzae, M. catarrhalis) due to B-lactamase production has caused only a minority of treatment failures with amoxicillin. Amoxicillin/clavulanic acid is first line treatment for infected bites of cat, dog or human.

ATC Code

J01CR02

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02238831 Clavulin (BID) 0.1831 0.1373
02539411 Jamp Amoxi Clav Suspension 0.1373 0.1373
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph